Skip to main content
EKTERLY 300 mg/1 tablet by KalVista Pharmaceuticals Ltd
EKTERLY, 300 mg/1, tablet Drug class: Plasma Kallikrein Inhibitor. Available on prescription only. Listed by KalVista Pharmaceuticals Ltd.
Prescription only

EKTERLY

sebetralstat

Listed by KalVista Pharmaceuticals Ltd

Strength
300 mg/1
Form
Tablet
Route
Oral
Class
Plasma Kallikrein Inhibitor

What it contains

  • Sebetralstat 300 mg/1

FDA record

Dosage form Tablet
Route Oral
Drug class Plasma Kallikrein Inhibitor
Approval route NDA — original brand approval
NDC code 82928-300
FDA application NDA219301
RxNorm concept 2717949
Package sizes listed 2
Marketed since July 2025

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.